InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Rottinghaus Scott T.. Officer active across 1 company, notably Enanta Pharmaceuticals INC. Aggregated, 12 filings have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €81k. History available since 8 August 2022. The latest transaction was filed on 8 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Rottinghaus Scott T. is Chief Medical Officer at Enanta Pharmaceuticals INC (XNAS). He has 11 filings in total, and across the 11 most recent filings we hold, the transactions run from 2022-08-11 to 2026-02-13, with sum_sell_eur at 80678 and sum_buy_eur at 0, and the modal transaction nature is Attribution.